rifampicin 150/ isoniazid 75 tablets orodispersible tablet
svizera labs private limited turma india - rifampicin 150/ isoniazid 75 tablets - orodispersible tablet - rifampicin 150/ isoniazid 75 tablets - various
rifampicin 150/ pyrazinamide 400/ isoniazid 75/ tablet
svizera labs pvt ltd turbhe,navi mumbai - rifampicin 150/ pyrazinamide 400/ isoniazid 75/ - tablet - rifampicin 150/ pyrazinamide 400/ isoniazid 75/ - various
rifampicin 60 mg & isoniazid 30 mg tablets dispersible tablet
macleods pharmaceuticals limited atlanta arcade church road near leela hotel - rifampicin 60 mg isoniazid 30 mg tablets - dispersible tablet - rifampicin bp 60 mg isoniazid bp30 mg - antimycobacterials: combinations of drugs for
rifampicin 60 mg & isoniazid 60 mg dispersible dispersible tablet
macleods pharmaceuticals limited atlanta arcade church road andheri ( east) mumbai - rifampicin 60 mg isoniazid 60 mg dispersible - dispersible tablet - rifampicin bp 60 mg isoniazid bp 60 mg - antimycobacterials: combinations of drugs for
rifampicin 60 mg isoniazid 30 mg & dispersible tablet
macleods pharmaceuticals limited atlanta arcade church road near leela hotel - rifampicin 60 mg isoniazid 30 mg pyrazinamide150 - dispersible tablet - rifampicin bp 60 mg isoniazid bp 30 mg - antimycobacterials: combinations of drugs for
rifampicin 75 mg isoniazid 50 mg & pyrazinamide dispersible tablet
macleods pharmaceuticals limited 304, atlanta arcade, marol church road, andheri - rifampicin isoniazid pyrazinamide - dispersible tablet - rifampicin bp 75 mg isoniazid bp 50 mg - antimycobacterials: combinations of drugs for
rifampicin 75 mg & isoniazid 50 mg dispersible dispersible tablet
macleods pharmaceuticals limited 304, atlanta arcade, marol church road, andheri - rifampicin isoniazid - dispersible tablet - rifampicin bp 75 mg isoniazid bp 50 mg - antimycobacterials: combinations of drugs for
rifadin rifampicin 300mg capsules blister pack
sanofi-aventis australia pty ltd - rifampicin, quantity: 300 mg - capsule - excipient ingredients: maize starch; magnesium stearate; gelatin; erythrosine; titanium dioxide; indigo carmine - tuberculosis. in the initial treatment and in re-treatment of patients with tuberculosis, rifadin must be used in conjunction with at least one other antituberculosis drug. leprosy. in the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the noninfectious state, which may be expected to occur in 3 to 4 months of treatment. as an alterantive drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other antileprosy drugs. as an alternative drug in all those patients having true drug allergy to the more commonly used antileprosy drugs. meningococcal disease. prophylaxis of meningococcal disease in close contacts of known cases and in carriers. (rifadin is not indicated for the treatment of meningococcal infections). haemophilus influenzae. prophylaxis of household contacts of patients with h. influenzae type b.
rifadin rifampicin 150mg capsules blister pack
sanofi-aventis australia pty ltd - rifampicin, quantity: 150 mg - capsule - excipient ingredients: maize starch; magnesium stearate; gelatin; erythrosine; titanium dioxide; indigo carmine - tuberculosis. in the initial treatment and in re-treatment of patients with tuberculosis, rifadin must be used in conjunction with at least one other antituberculosis drug. leprosy. in the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the noninfectious state, which may be expected to occur in 3 to 4 months of treatment. as an alterantive drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other antileprosy drugs. as an alternative drug in all those patients having true drug allergy to the more commonly used antileprosy drugs. meningococcal disease. prophylaxis of meningococcal disease in close contacts of known cases and in carriers. (rifadin is not indicated for the treatment of meningococcal infections). haemophilus influenzae. prophylaxis of household contacts of patients with h. influenzae type b.
rifadin rifampicin 600mg powder for injection vial with diluent ampoule
sanofi-aventis australia pty ltd - rifampicin, quantity: 600 mg - injection, powder for - excipient ingredients: sodium hydroxide; sodium formaldehyde sulfoxylate - tuberculosis. in the initial treatment and in re-treatment of patients with tuberculosis, rifadin must be used in conjunction with at least one other antituberculosis drug. leprosy. in the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the noninfectious state, which may be expected to occur in 3 to 4 months of treatment. as an alterantive drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other antileprosy drugs. as an alternative drug in all those patients having true drug allergy to the more commonly used antileprosy drugs. meningococcal disease. prophylaxis of meningococcal disease in close contacts of known cases and in carriers. (rifadin is not indicated for the treatment of meningococcal infections). haemophilus influenzae. prophylaxis of household contacts of patients with h. influenzae type b.